Stephen G Young

Title: The Innovations of Stephen G Young

Introduction

Stephen G Young is a notable inventor based in Hillsborough, CA (US). He has made significant contributions to the field of biochemistry, particularly in the development of methods for determining low-density lipoproteins (LDL) in plasma. With a total of 2 patents, his work has implications for improving health diagnostics.

Latest Patents

Young's latest patents focus on DNA encoding recombinant lipoprotein antigens. These patents describe methods and compositions for determining the level of LDL in plasma. The native apoprotein B-100 (apo B-100) present in LDL particles is immunologically mimicked by a polypeptide of his invention. This polypeptide includes an amino acid residue sequence corresponding to a pan epitope region of the target apoprotein. A preferred polypeptide is a fusion protein that simultaneously mimics native apo B-100 and native apo A-I. Improved assay systems and methods for determining HDL and LDL levels in a body fluid sample are also described in his patents.

Career Highlights

Stephen G Young is affiliated with The Scripps Research Institute, where he has been able to leverage his expertise in biochemistry and molecular biology. His innovative approaches have contributed to advancements in the understanding of lipid metabolism and cardiovascular health.

Collaborations

Young has collaborated with notable colleagues such as Richard S Smith and Linda K Curtiss. These collaborations have further enhanced the impact of his research and innovations in the field.

Conclusion

Stephen G Young's contributions to the field of biochemistry through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in health diagnostics and understanding of lipid-related diseases.